Skip to main content

Table 4 Variables associated with polypharmacy

From: Psychotropic medication use in people living with severe and persistent mental illness in the Australian community: a cross-sectional study

Variable

Antipsychotic

Antidepressant

Mood Stabiliser

Crude OR (95% CI)

a Adjusted OR (95% CI)

Crude OR (95% CI)

Adjusted OR (95% CI)

Crude OR (95% CI)

Adjusted OR (95% CI)

Age

1.0* (0.9,1.0)

1.0 (1.0,1.0)

1.0 (1.0,1.1)

1.0* (1.0,1.1)

1.0 (1.0,1.0)

1.0 (1.0,1.0)

Gender

 Reference = Male

0.5* (0.3,1.0)

0.5* (0.2,1.0)

3.0* (1.1,8.2)

2.5 (0.9,7.3)

1.3 (0.5,3.1)

1.7 (0.6,4.6)

Geographic location

 Reference = Metropolitan

0.9 (0.5,1.6)

0.8 (0.4,1.7)

1.3 (0.6,3.0)

1.6 (0.6,3.9)

1.7 (0.7,3.9)

1.3 (0.5,3.3)

Mental illness

 Reference = 1 condition

1.5 (0.8,2.8)

1.4 (0.7,3.1)

1.6 (0.6,4.6)

2.2 (0.7,6.7)

0.4* (0.2,0.9)

0.6 (0.2,1.6)

Admission (last 6 months)

 Reference = Yes

1.3 (0.6,2.6)

1.0 (0.4,2.4)

1.7 (0.7,4.1)

1.9 (0.7,5.1)

0.7 (0.3,2.2)

0.7 (0.2,2.3)

Prescriber

 Reference = GP only

 Psychiatrist only

bMultiple prescribers

1.0 (1.0,1.0)

5.3** (2.3,12.0)

2.8* (1.2,6.2)

1.0 (1.0,1.0)

6.2** (2.5,15.1)

3.0* (1.2,7.3)

1.0 (1.0,1.0)

2.1 (0.7,6.5)

1.9 (0.7,4.9)

1.0 (1.0,1.0)

2.3 (0.7,7.7)

2.0 (0.7,5.8)

1.0 (1.0,1.0)

2.1 (0.7,5.8)

0.6 (0.2,1.8)

1.0 (1.0,1.0)

2.08 (0.68,6.36)

0.57 (0.16,1.97)

  1. *p< 0.05, **p< 0.001 ; OR, odds ratio; CI, confidence interval; GP, general practitioner
  2. aAll variables were included in the adjusted models
  3. bMultiple prescribers consisted of GP and psychiatrist, GP and hospital doctor, or psychiatrist, hospital doctor and nurse practitioner